➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
McKinsey
Baxter
Harvard Business School

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

Details for Biologics License Application: 761108

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for BLA: 761108
Tradename:ULTOMIRIS
Applicant:Alexion Pharm
Ingredient:ravulizumab-cwvz
Patents:7
Approval Date:Oct 18, 2019
Suppliers: see list1

US Patents for BLA: 761108

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial Alexion Pharmaceuticals, Inc. (Boston, MA) 2034-03-07 RX Orphan company
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial ALEXION PHARMACEUTICALS, INC. (Cheshire, CT) 2034-03-07 RX Orphan company
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial Alexion Pharmaceuticals, Inc. (Cheshire, CT) 2034-03-07 RX Orphan company
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial Alexion Pharmaceuticals, Inc. (Cheshire, CT) 2034-03-07 RX Orphan company
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial Alexion Pharmaceuticals, Inc. (New Haven, CT) 2034-03-07 RX Orphan company
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial Alexion Pharmaceuticals, Inc. (New Haven, CT) 2034-03-07 RX Orphan company
Alexion Pharm ULTOMIRIS ravulizumab-cwvz INJECTABLE;INJECTION 761108 001 2019-10-18   Start Trial Alexion Pharmaceuticals, Inc. (New Haven, CT) 2034-03-07 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Express Scripts
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.